| Literature DB >> 29695707 |
Franziska A Hägele1,2, Franziska Büsing1,2, Alessa Nas1, Julian Aschoff3, Lena Gnädinger1, Ralf Schweiggert3, Reinhold Carle3,4, Anja Bosy-Westphal5,6.
Abstract
Sugar-containing beverages like orange juice can be a risk factor for obesity and type 2 diabetes although the underlying mechanisms are less clear. We aimed to investigate if intake of orange juice with or in-between meals differently affects energy balance or metabolic risk. Twenty-six healthy adults (24.7 ± 3.2 y; BMI 23.2 ± 3.2 kg/m2) participated in a 4-week cross-over intervention and consumed orange juice (20% of energy requirement) either together with 3 meals/d (WM) or in-between 3 meals/d (BM) at ad libitum energy intake. Basal and postprandial insulin sensitivity (primary outcome), daylong glycaemia, glucose variability and insulin secretion were assessed. Body fat mass was measured by air-displacement plethysmography. After BM-intervention, fat mass increased (+1.0 ± 1.8 kg; p < 0.05) and postprandial insulin sensitivity tended to decrease (ΔMatsudaISI: -0.89 ± 2.3; p = 0.06). By contrast, after WM-intervention fat mass and gamma-glutamyl transferase (GGT) decreased (-0.30 ± 0.65 kg; -2.50 ± 3.94; both p < 0.05), whereas glucose variability was higher (ΔMAGE: +0.45 ± 0.59, p < 0.05). Daylong glycaemia, insulin secretion, changes in basal insulin sensitivity, and triglycerides did not differ between WM- and BM-interventions (all p > 0.05). In young healthy adults, a conventional 3-meal structure with orange juice consumed together with meals had a favorable impact on energy balance, whereas juice consumption in-between meals may contribute to a gain in body fat and adverse metabolic effects.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29695707 PMCID: PMC5916905 DOI: 10.1038/s41387-018-0031-3
Source DB: PubMed Journal: Nutr Diabetes ISSN: 2044-4052 Impact factor: 5.097
Fig. 1Flow diagram of the cross-over study protocol.
BM orange juice in-between meals, CGM continuous glucose monitoring, OGTT oral glucose tolerance test, WM orange juice with meals
Comparison of energy balance and metabolic risk between interventions with orange juice with meals and in-between mealsa
| WM | BM | ∆BM-WM | |||||
|---|---|---|---|---|---|---|---|
| T1 | T2 | ∆T2-T1 | T3 | T4 | ∆T4-T3 | ∆∆(T4-T3)–(T1-T2) | |
| Energy balance | |||||||
| weight, kg | 70.3 ± 14.1 | 70.4 ± 14.4 | +0.13 ± 0.82 | 70.1 ± 14.5 | 70.3 ± 14.5 | +0.21 ± 0.94 | NS |
| FM, kg | 15.3 ± 6.8 | 15.0 ± 6.7 | −0.30 ± 0.65* | 14.1 ± 6.3 | 15.1 ± 6.6 | +1.02 ± 1.81** | |
| FMI, kg/m2 | 5.15 ± 2.3 | 5.05 ± 2.2 | −0.10 ± 0.22* | 4.78 ± 2.1 | 5.08 ± 2.2 | +0.30 ± 0.58* | |
| Metabolic risk | |||||||
| HOMA-IR | 1.97 ± 1.1 | 1.79 ± 1.0 | −0.18 ± 0.65 | 1.62 ± 0.8 | 1.63 ± 0.6 | +0.01 ± 0.67 | |
| MatsudaISI | 6.01 ± 2.7 | 6.08 ± 2.7 | +0.07 ± 1.92 | 7.11 ± 2.9 | 6.21 ± 2.3 | −0.89 ± 2.33 | NS |
| Fructosamine, µmol/L | 236.1 ± 25.3 | 234.0 ± 15.9 | −2.0 ± 20.2 | 233.3 ± 13.0 | 236.0 ± 15.6 | 2.7 ± 15.7 | NS |
| GGT, U/L | 17.9 ± 7.9 | 15.4 ± 6.7 | −2.50 ± 3.94** | 16.9 ± 7.3 | 16.4 ± 6.6 | −0.42 ± 4.49 | NS |
| TG, mg/dL | 100.9 ± 57.0 | 98.5 ± 47.7 | −2.35 ± 45.83 | 87.9 ± 42.0 | 89.8 ± 34.8 | +1.92 ± 33.80 | NS |
BM orange juice in-between meals, FM fat mass, FMI fat mass index, GGT gamma-glutamyl transferase, T1 study day before WM-intervention, T2 study day after WM-intervention, T3 study day before BM-intervention, T4 study day after BM-intervention, WM orange juice with meals
aValues are means ± SDs, n = 26
*p < 0.05; **p < 0.01, paired t-test or Wilcoxon-test
Comparison of daylong glycemia and insulin secretion between interventions with orange juice with meals (WM) and in-between meals (BM)a
| WM | BM | ∆BM-WM | |
|---|---|---|---|
| iAUC glucose, mg/dL x 18 h | 289 ± 89 | 260 ± 72 | −29.56 ± 93.55 |
| MAGE | 2.08 ± 0.3 | 2.52 ± 0.5 | +0.45 ± 0.59** |
| MAX glucose, mg/dL | 151 ± 12 | 143 ± 13 | −7.88 ± 16.37* |
| C-peptide, µg/d | 70.0 ± 37.0 | 70.6 ± 41.9 | +0.52 ± 39.19 |
iAUC incremental area under the glucose curve for 18 h, MAGE mean amplitude of glycemic excursions, MAX glucose maximal interstitial glucose value per day
aValues are means ± SD, n = 26
*p < 0.05, **p < 0.01, paired t-test
Fig. 2Daylong glycemia (CGM) for all participants (A, n = 26) and for one exemplary participant (B, n = 1) during interventions with orange juice with meals (WM) and in-between meals (BM). Glucose variability during the day is only visible in the individual day profile since exact meal times were not prescribed by the study protocol and glucose variability is therefore averaged out by the mean value of all subjects